Estimation of recent and long-term malaria transmission in a population by antibody testing to multiple Plasmodium falciparum antigens.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMC 4168304)

Published in J Infect Dis on April 15, 2014


Bartholomew N Ondigo1, James S Hodges2, Kathleen F Ireland3, Ng'wena G Magak4, David E Lanar5, Sheetij Dutta5, David L Narum6, Gregory S Park7, Ayub V Ofulla7, Chandy C John8

Author Affiliations

1: Department of Biomedical Science and Technology, Maseno University Center for Global Health Research, Kenya Medical Research Institute, Kisumu.
2: Division of Biostatistics, School of Public Health, University of Minnesota.
3: Department of Pediatrics, University of Minnesota Medical School.
4: Department of Medical Physiology, Maseno University, Kenya.
5: Center for Global Health Research, Kenya Medical Research Institute, Kisumu.
6: Malaria Vaccine Branch, Walter Reed Army Institute for Research, Silver Spring.
7: Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institute of Health, Rockville, Maryland.
8: Department of Pediatrics, University of Minnesota Medical School Center for Global Health Research, Kenya Medical Research Institute, Kisumu.

Articles citing this

Acquisition of Functional Antibodies That Block the Binding of Erythrocyte-Binding Antigen 175 and Protection Against Plasmodium falciparum Malaria in Children. Clin Infect Dis (2015) 1.42

Serological markers for monitoring historical changes in malaria transmission intensity in a highly endemic region of Western Kenya, 1994-2009. Malar J (2014) 1.14

Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities. Proc Natl Acad Sci U S A (2015) 1.13

Serologically defined variations in malaria endemicity in Pará state, Brazil. PLoS One (2014) 1.02

Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria. FEMS Microbiol Rev (2016) 1.02

Sample size determination for estimating antibody seroconversion rate under stable malaria transmission intensity. Malar J (2015) 0.91

Antibody acquisition models: A new tool for serological surveillance of malaria transmission intensity. Sci Rep (2016) 0.87

Biosignatures of Exposure/Transmission and Immunity. Am J Trop Med Hyg (2015) 0.84

Implementation and application of a multiplex assay to detect malaria-specific antibodies: a promising tool for assessing malaria transmission in Southeast Asian pre-elimination areas. Malar J (2015) 0.81

Decline in childhood iron deficiency after interruption of malaria transmission in highland Kenya. Am J Clin Nutr (2014) 0.81

Multiple comparisons analysis of serological data from an area of low Plasmodium falciparum transmission. Malar J (2015) 0.79

Differing rates of antibody acquisition to merozoite antigens in malaria: implications for immunity and surveillance. J Leukoc Biol (2016) 0.78

Serological markers to measure recent changes in malaria at population level in Cambodia. Malar J (2016) 0.78

Malaria and Age Variably but Critically Control Hepcidin Throughout Childhood in Kenya. EBioMedicine (2015) 0.76

Serological signatures of declining exposure following intensification of integrated malaria control in two rural Senegalese communities. PLoS One (2017) 0.76

Longevity of Genotype-Specific Immune Responses to Plasmodium falciparum Merozoite Surface Protein 1 in Kenyan Children from Regions of Different Malaria Transmission Intensity. Am J Trop Med Hyg (2016) 0.75

Effectiveness of a serological tool to predict malaria transmission intensity in an elimination setting. BMC Infect Dis (2017) 0.75

Evaluation of Immunoglobulin G Responses to Plasmodium falciparum and Plasmodium vivax in Malian School Children Using Multiplex Bead Assay. Am J Trop Med Hyg (2016) 0.75

Modelling dynamic change of malaria transmission in holoendemic setting (Dielmo, Senegal) using longitudinal measures of antibody prevalence to Plasmodium falciparum crude schizonts extract. Malar J (2017) 0.75

A Malaria-Resistant Phenotype with Immunological Correlates in a Tanzanian Birth Cohort Exposed to Intense Malaria Transmission. Am J Trop Med Hyg (2017) 0.75

Articles cited by this

High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol (1993) 17.06

Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci U S A (2005) 6.39

Humoral immunity due to long-lived plasma cells. Immunity (1998) 6.35

Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol (2003) 5.51

Serology: a robust indicator of malaria transmission intensity? Trends Parasitol (2007) 3.63

Maintenance of serum antibody levels. Annu Rev Immunol (2005) 3.20

Maintenance of B-cell memory by long-lived cells generated from proliferating precursors. Nature (1990) 3.14

Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar J (2008) 3.02

Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008. Emerg Infect Dis (2010) 2.59

Using serological measures to monitor changes in malaria transmission in Vanuatu. Malar J (2010) 2.47

Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax. PLoS Pathog (2010) 2.30

IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life. Malar J (2007) 2.30

Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness. Infect Immun (2009) 2.22

Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific. Infect Immun (2008) 2.18

Long-lived plasma cells: a mechanism for maintaining persistent antibody production. Curr Opin Immunol (1998) 2.10

Mechanisms that determine plasma cell lifespan and the duration of humoral immunity. Immunol Rev (2010) 1.99

Antibodies to variable Plasmodium falciparum-infected erythrocyte surface antigens are associated with protection from novel malaria infections. Immunol Lett (2000) 1.89

Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia. Clin Infect Dis (2010) 1.79

Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry. Blood (1990) 1.76

Plasma cell development and survival. Immunol Rev (2010) 1.74

Low prevalence of Plasmodium falciparum infection among asymptomatic individuals in a highland area of Kenya. Trans R Soc Trop Med Hyg (2005) 1.73

Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection. Am J Trop Med Hyg (2005) 1.70

Microscopy underestimates the frequency of Plasmodium falciparum infection in symptomatic individuals in a low transmission highland area. Am J Trop Med Hyg (2008) 1.44

Possible interruption of malaria transmission, highland Kenya, 2007-2008. Emerg Infect Dis (2009) 1.44

Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children. J Infect Dis (2008) 1.32

Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria. J Infect Dis (2013) 1.30

Antigen dependent and independent mechanisms that sustain serum antibody levels. Vaccine (2003) 1.27

The quantity and quality of African children's IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malaria. PLoS One (2009) 1.24

Low prevalence of antibodies to preerythrocytic but not blood-stage Plasmodium falciparum antigens in an area of unstable malaria transmission compared to prevalence in an area of stable malaria transmission. Infect Immun (2008) 1.17

Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults. Malar J (2011) 1.03

The seroepidemiology of malaria in Middle America. II. Studies on the Pacific coast of Costa Rica. Am J Trop Med Hyg (1975) 1.01

Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria. Pediatr Infect Dis J (2011) 1.01

High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria. PLoS One (2012) 1.01

Evaluation of antibody response to Plasmodium falciparum in children according to exposure of Anopheles gambiae s.l or Anopheles funestus vectors. Malar J (2007) 0.98

Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana. Malar J (2011) 0.96

The seroepidemiology of malaria in Middle America. III. Serologic assessment of localized Plasmodium falciparum epidemics. Am J Trop Med Hyg (1976) 0.92

Standardization and validation of a cytometric bead assay to assess antibodies to multiple Plasmodium falciparum recombinant antigens. Malar J (2012) 0.90

Exploiting human memory B cell heterogeneity for improved vaccine efficacy. Front Immunol (2011) 0.85